SEC Form 4 · accession 0001178913-26-003955
Entera Bio Ltd. · ENTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Haya Taitel
Director
Period of report
Aug 7, 2026
Accepted (ET)
Aug 7, 2026 · 4:22 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001638097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value NIS 0.0000769 per share | Aug 7, 2026 | A | 20,790 | $0.00 | A | 119,269 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") awarded these shares to the Reporting Person in lieu of the cash fees the Reporting Person was entitled to for services rendered as a director of the Company for the first quarter and second quarter of 2026. This grant of shares was approved by the Board on August 5, 2026, subject to the filing by the Company of a Registration Statement on Form S-8 registering the shares, which occurred on August 7, 2026.